Cash and Cash Equivalents |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Text block [abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||
| Cash and Cash Equivalents | Note 13: Cash and Cash Equivalents The components of cash and cash equivalents include the following:
Of total cash and cash equivalents, $140 million and $115 million as of December 31, 2025 and 2024, respectively, were held in subsidiaries which have regulatory restrictions, contractual restrictions or operate in countries where exchange controls and other legal restrictions apply and were therefore not available for general use by the Company. |
||||||||||||||||||||||||||||||||||||||||||||||||